Table 1.
Dataset | Training | Validation | Test |
---|---|---|---|
Number of scans | 276 | 104 | 71 |
Pretreatment scans | 157 | 53 | 71 |
Post-NACT scans | 119 | 51 | 0 |
Patient age [years] | |||
Median | 65.5 | 65.5 | 63 |
Min–max | 29–90 | 35–85 | 41–80 |
Pixel spacing [mm] | |||
Median | 0.68 | 0.76 | 0.77 |
Min–max | 0.53–0.93 | 0.61–0.96 | 0.57–0.98 |
Slice thickness [mm] | |||
Median | 5.0 | 5.0 | 5.0 |
Min–max | 1.25–5.0 | 1.5–5.0 | 2.0–7.5 |
Pelvic/ovarian tumour | |||
Number of scans showing tumour in this location | 246 | 102 | 69 |
Mean volume [cm3] | 275 | 241 | 381 |
Mean number of connected components | 2.4 | 2.6 | 2.4 |
Omental tumour | |||
Number of scans showing tumour in this location | 198 | 98 | 56 |
Mean volume [cm3] | 119 | 197 | 146 |
Mean number of connected components | 6.7 | 5.3 | 5.7 |
Due to the anonymisation of the datasets, no information on the ethnicity of the patients was prevalent and the patient age was not available in 14 out of 71 patients in the test data. Additional information on the acquisition settings of the computed tomography examination is given in the Supplementary Materials. NACT Neoadjuvant chemotherapy